[Federal Register Volume 85, Number 96 (Monday, May 18, 2020)]
[Notices]
[Pages 29728-29729]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-10495]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI Program Project III (P01).
    Date: June 18-19, 2020.
    Time: 8:00 a.m. to 12:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove 9609 Medical Center 
Drive, Room

[[Page 29729]]

7W240 Rockville, MD 20850 (Telephone Conference Call).
    Contact Person: Hasan Siddiqui, Ph.D., Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W240, Rockville, MD 20850 240-276-5122, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; UH2/3 Assay Validation of High-Quality Markers for Clinical 
Studies in Cancer.
    Date: June 24, 2020.
    Time: 11:00 a.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W244, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: John Paul Cairns, Ph.D., Scientific Review 
Officer, Research Programs Review Branch, Division of Extramural 
Activities, 9609 Medical Center Drive, Room 7W244, National Cancer 
Institute, NIH, Bethesda, MD 20892, 240-276-5415, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; SEP-8: NCI Clinical and Translational R21 and Omnibus R03 
Review.
    Date: July 1-2, 2020.
    Time: 10:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W242, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Zhiqiang Zou, M.D., Ph.D., Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, 7W242, 
Bethesda, MD 20892 240-276-6372, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; HIV/AIDS and the Tumor Niche.
    Date: July 9, 2020.
    Time: 10:00 a.m. to 5:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W618, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Mukesh Kumar, Ph.D., Scientific Review Officer, 
Research Program Review Branch, Division of Extramural Activities, 
9609 Medical Center Drive, Room 7W618, National Cancer Institute, 
NIH, Rockville, MD 20850 240-276-6611, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: May 12, 2020.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-10495 Filed 5-15-20; 8:45 am]
BILLING CODE 4140-01-P